The OHSU Knight Cancer Institute has launched the largest program of its kind in the world: the Center for Cancer Early Detection and Research (CEDAR). Early detection remains one of the largest unmet needs in cancer research — yet we know that when we find and treat cancer earlier, more people live. That’s easy to […]
OHSU Doernbecher Children’s Hospital has recruited Yoon-Jae Cho, M.D., thanks to a new endowed professorship from Wayne and Sandy Ericksen. Dr. Cho is the chief of the Division of Pediatric Neurology, Ericksen Family Endowed Professor for Research, and scientific director of the Pediatric Brain Tumor Program. He is also a graduate of OHSU School of […]
OHSU Knight Cancer Institute Director Brian Druker, M.D., is famous for ignoring the conventional wisdom. He disregarded those who called his research “voodoo science” and his work resulted in GleevecTM – a landmark drug proven effective in 10 types of cancer. In selecting Sadik Esener, Ph.D., to lead the institute’s newly established Center for Early […]
Fifteen years ago, an astounding breakthrough changed the way the world treats cancer. The discovery by Brian Druker, M.D., now director of the OHSU Knight Cancer Institute, turned chronic myeloid leukemia (CML) from a deadly disease with a very short life expectancy into a treatable condition managed by a daily pill, called Gleevec. It was […]
Missions to deep space involve risk. The National Space Biomedical Research Institute (NSBRI) — which works with NASA — has tapped OHSU’s Jonathan Lindner, MD to find better ways to screen astronaut candidates for cardiovascular damage before they reach deep space.
Today is a global celebration of giving — an opportunity to support the causes that matter the most to you. Will you join us?
Give Now
